Insiders · Profile

Session R.A. II

10% owner at Taysha Gene Therapies. Filing since 23 Nov 2021. CIK 0001701846

Company
Date
Role
Action
Shares
Amount
Of holding
13 Jul 2023
10% owner
Sold at will
5,344
$3.74K
0.1%
12 Jul 2023
10% owner
Sold at will
80,528
$57.03K
0.9%
23 Jun 2023
10% owner
Sold at will
18,100
$12.74K
0.2%
22 Jun 2023
10% owner
Sold at will
10,508
$7.38K
0.1%
21 Jun 2023
10% owner
Sold at will
138,962
$97.63K
1.5%
20 Jun 2023
10% owner
Sold at will
295,653
$210.21K
3.1%
23 Nov 2021
President and CEO
Bought
42,518
$529.10K
0.5%
7 decisions on file.